Interesting Research in Heart Disease

This article describes some current research which I learned about through my interest in investments. A biotech company I invested in this week will report on some research tomorrow involving the injection of stem cells into the hearts of patients with recent heart attacks in a Phase 1 study. The results, I understand, were very positive and I expect the stock to do quite well, but the benefits to attack victims down the road may be even better. The company is Osiris Therapeutics Inc., stock symbol OSIR.